IDiyas

For the Inventor, By the Inventor

Pleasanton, CA, United States of America

Yooli Kim Light

USPTO Granted Patents = 11

Average Co-Inventor Count = 4.3

ph-index = 2

Forward Citations = 17(Granted Patents)


Company Filing History:

goldMedal11 out of 1,016 
 
National Technology & Engineering Solutions of Sandia, LLC
 patents

Years Active: 2017-2025

Loading Chart...
11 patents (USPTO):Explore Patents
1. 12421306 - Lung-targeting single-domain antibodies and purification methods (2025-09-23),
2. 12098200 - Brain-targeting single domain antibodies and purification methods (2024-09-24),
3. 12098186 - Multivalent anti-SARS-CoV-2 nanobodies (2024-09-24),
4. 12091446 - SARS-CoV-2 variant nanobodies and constructs comprising such nanobodies (2024-09-17),
5. 12024551 - Coronavirus neutralizing humanized antibodies and uses thereof (2024-07-02),
6. 11999805 - Peptide inhibitors of CRISPR-Cas9 (2024-06-04),
7. 11807877 - CRISPR/Cas activity assays and compositions thereof (2023-11-07),
8. 11473141 - Endpoint detection of amplified nucleic acids (2022-10-18),
9. 10724091 - Endpoint detection of amplified nucleic acids (2020-07-28),
10. 10590477 - Method and apparatus for purifying nucleic acids and performing polymerase chain reaction assays using an immiscible fluid (2020-03-17),
11. 9803238 - Method and apparatus for purifying nucleic acids and performing polymerase chain reaction assays using an immiscible fluid (2017-10-31),

Title: Yooli Kim Light: Innovator in Targeted Antibody Technologies

Introduction

Yooli Kim Light is a prominent inventor based in Pleasanton, California, known for his significant contributions to the field of biotechnology. With a total of 11 patents to his name, he has made remarkable advancements in the development of single-domain antibodies that target specific tissues in the human body.

Latest Patents

Among his latest patents are innovative methods for creating lung-targeting single-domain antibodies. These antibodies are designed to bind to human or mammalian lung tissue, facilitating the transport of beneficial biochemical or pharmaceutical species. Additionally, he has developed purification methods for in vivo treatment or testing, enhancing the efficacy of these antibodies in medical applications. Another notable patent involves brain-targeting single-domain antibodies that can pass the blood-brain barrier. This technology allows for targeted treatment and diagnosis of diseases affecting the brain, showcasing his commitment to addressing critical health challenges.

Career Highlights

Yooli Kim Light is currently employed at National Technology & Engineering Solutions of Sandia, LLC, where he continues to push the boundaries of scientific research and innovation. His work has not only contributed to the advancement of antibody technologies but has also paved the way for new therapeutic approaches in medicine.

Collaborations

Throughout his career, Yooli has collaborated with talented individuals such as Brooke Nicole Harmon and Chung-Yan Koh. These partnerships have fostered a collaborative environment that enhances the development of groundbreaking technologies.

Conclusion

Yooli Kim Light's innovative work in the field of targeted antibody technologies exemplifies the impact of dedicated inventors in advancing medical science. His contributions are paving the way for new treatments and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…